- Free from Publisher TJ Orchard, T Costacou, A Kretowski, RW … - Diabetes Care, 2006 - Am Diabetes Assoc Although the increased risk of premature heart disease in type 1 diabetes has
been recognized for some time, the underlying pathogenesis is still poorly
understood. The most likely factor, a priori, to account for this increased ... Cited by 33 - Related articles - All 6 versions
D Russell-Jones, R Khan - Diabetes Obesity and Metabolism, 2007 - interscience.wiley.com Insulin therapy or intensification of insulin therapy commonly results in weight
gain in both type 1 and type 2 diabetes. This weight gain can be excessive,
adversely affecting cardiovascular risk profile. The spectre of weight gain ... Cited by 30 - Related articles - BL Direct - All 3 versions
- Free from Publisher SM Strowig, P Raskin - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Both groups experienced a significant reduction in HbA 1c (A1C) level
(rosiglitazone: 7.9 ± 1.3 to 6.9 ± 0.7%, P < 0.0001; placebo: 7.7 ± 0.8 to
7.0 ± 0.9%, P = 0.002) and a significant increase in weight ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org IH de Boer, SD Sibley, B Kestenbaum, JN … - Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol Weight gain and central obesity are associated with insulin resistance,
hypertension, and dyslipidemia in type 1 diabetes. These metabolic abnormalities
are risk factors for kidney disease in the general population, but data ... Cited by 17 - Related articles - BL Direct - All 10 versions
E Larger - Diabetes and Metabolism, 2005 - Elsevier This review presents recent data on weight gain when on insulin treatment in
type 1 and type 2 diabetic patients. In both types of diabetes, the excess
weight gain with intensified insulin therapy compared with conventional ... Cited by 16 - Related articles - BL Direct - All 3 versions
AN Jacob, K Salinas, B Adams-Huet, P … - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com Methods: This was an open-label prospective study of insulin therapy of 6 months
duration in an academic medical centre. Twenty-one subjects with type 1 diabetes
were enrolled. The goal was to achieve an haemoglobin A1c (HbA1c) in the ... Cited by 5 - Related articles - BL Direct - All 4 versions
SA Dib - Arq Bras Endocrinol Metab, 2006 - SciELO Brasil A resistência à insulina (RI) pode desempenhar um papel, na história natural
do diabetes melito do tipo 1 (DM1), maior do que o habitualmente reconhecido.
Nas últimas décadas, este papel se tornou mais evidente com o aumento da ... Cited by 5 - Related articles - Cached - All 3 versions
P Diabetes - Pediatric Diabetes, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - BL Direct - All 3 versions
SA Dib - Arquivos Brasileiros de Endocrinologia & Metabologia, 2006 - SciELO Brasil A resistência à insulina (RI) pode desempenhar um papel, na história natural
do diabetes melito do tipo 1 (DM1), maior do que o habitualmente reconhecido.
Nas últimas décadas, este papel se tornou mais evidente com o aumento da ... Cited by 3 - Related articles - Cached - All 2 versions
